Reliable Human Plasma for Precision Research

 

Plasma samples serve as windows into systemic biology, capturing circulating proteins, nucleic acids, metabolites, and other analytes that drive biomarker research and diagnostic development. While MT Group specializes in prospective plasma collections designed around your specific study parameters—including patient populations, anticoagulants, processing protocols, and clinical data requirements—we also maintain a curated plasma bank for projects requiring rapid specimen access.

From standard EDTA or Streck-tube based anticoagulants to specialized processing like double-spin centrifugation, we customize plasma collections to meet the precise requirements of proteomics, metabolomics, liquid biopsy, and immunoassay applications.

Inquire About Plasma Samples

Plasma Samples & Research Applications

MT Group has supported hundreds of plasma collections for pharmaceutical, biotechnology, and laboratory diagnostics companies since our founding in 2003. Our established network provides access to diverse disease populations as well as healthy, at-risk, and high-risk control cohorts, enabling comparative studies and robust experimental designs.

Longitudinal, multi-timepoint collections are a core specialty, allowing researchers to track disease progression, treatment response, and biomarker evolution over time. As an experienced human blood supplier, we bring over two decades of expertise in plasma procurement, processing, and delivery to support your most critical research objectives.

Request Available Plasma Inventory

Why Leading Researchers
Choose MT Group Plasma Samples

MT Group's approach to human plasma procurement is built on realistic feasibility assessment and transparent communication, not overpromising.

We ask detailed questions upfront to fully understand your study design, then conduct thorough site feasibility evaluations to provide honest projections about enrollment potential and timelines. We frequently take over plasma collections that other CROs have abandoned after overpromising and underdelivering, getting stalled studies back on track.

By setting accurate expectations from the start and maintaining close project oversight, MT Group protects your research timelines and budget. When you work with an experienced human blood supplier that prioritizes feasibility over optimism, your collection succeeds.

Disease State Plasma Collections

MT Group collects human plasma from patients across diverse disease populations, providing disease state plasma samples with the comprehensive clinical annotation, customizable processing, and longitudinal collection capabilities that translational research demands. Our disease state plasma for research spans oncology, autoimmune and inflammatory conditions, metabolic disease, neurological conditions, and other therapeutic areas—each with disease-specific case report forms and validated clinical data. Learn more about our disease state plasma capabilities →

Quality Assurance & Services

Ethical procurement, rigorous reviews and full traceability ensure specimens you can trust.

IRB‑Approved Collections

All MT Group tissue collections are conducted under Institutional Review Board (IRB) approval, ensuring ethical procurement and full regulatory compliance. This commitment guarantees that every specimen is collected with proper informed consent and adheres to the highest standards of human subject research protections.

Clinical Data Validation

MT Group maintains a dedicated clinical data team that meticulously reviews all case report forms from collection sites for completeness and internal consistency before resolving any discrepancies found with the clinical site. We understand how critical this data is to research; nearly any information collected as part of standard clinical care is routinely captured and non-standard-of-care data collection can often be arranged to meet specific study requirements.

Specimen Replacement Guarantee

MT Group stands behind the quality of every plasma sample delivered. If any specimen fails to meet agreed-upon specifications due to shipping issues, handling concerns, or quality parameters, we will replace the specimen at no additional cost, ensuring your research timelines and budgets remain on track.

Chain of Custody & Documentation

Comprehensive documentation accompanies each plasma specimen, including collection details, processing protocols, anticoagulant type, spin parameters, storage conditions, and complete clinical data. This full chain of custody provides traceability and the clinical context necessary for robust, reproducible research outcomes.

Why Leading Researchers Choose MT Group

"MT Group's responsiveness and flexibility have been exceptional. They consistently delivered rare, high-quality samples that were essential to our research, with impeccable service and follow-up at every step. Their ability to source difficult-to-find specimens and their quick attention to every inquiry made all the difference for our program. We're deeply grateful for their partnership."

— CEO, Cell Therapy Company

"MT Group's clinical expertise during the study design phase was exceptional. Their team brings valuable insights that strengthen our collection protocols and their exhaustive attention to detail ensures nothing is overlooked. This combination of scientific knowledge and meticulous planning has been instrumental in building powerful prospective tissue collections that meet our research objectives."

— Senior Scientist, Top 10 Biopharmaceutical Company

"The communication has been stellar throughout our collaboration. The weekly study updates keep us fully informed, and the detailed collection notification emails make accessioning samples extremely easy for our lab partners. The project management team is responsive and proactive—it's exactly what we need to keep our studies running smoothly."

— Business Operations Manager, Liquid Biopsy Company

Contact MT Group

Complete the form below to discuss your tissue requirements with our experts.
No obligation consultation. Response within one business day.